Finasteride 非那雄胺
3
conditions reviewed
A
top tier
A 🔵 A Moderate Evidence
Benign Prostatic Hyperplasia
良性攝護腺肥大（BPH）
Published ⚠️ Moderate market risk
→
B 🟡 B Preliminary Evidence Androgenetic Alopecia
雄性禿（雄性激素性脫髮）
Published with Warning ⚠️ Moderate market risk
→
U ⚫ U Unverified Post Finasteride Syndrome
停藥後症候群（PFS）
Disputed ⚠️ Moderate market risk
→